{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T14:08:24Z","timestamp":1745417304495},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T00:00:00Z","timestamp":1529971200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anaesthesist"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s00101-018-0462-1","type":"journal-article","created":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T05:41:22Z","timestamp":1529991682000},"page":"529-532","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["S1-Leitlinie maligne Hyperthermie"],"prefix":"10.1007","volume":"67","author":[{"given":"F.","family":"Wappler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,26]]},"reference":[{"key":"462_CR1","first-page":"204","volume":"59","author":"Deutsche Gesellschaft f\u00fcr An\u00e4sthesiologie und Intensivmedizin","year":"2018","unstructured":"Deutsche Gesellschaft f\u00fcr An\u00e4sthesiologie und Intensivmedizin (2018) S1-Leitlinie: Therapie der malignen Hyperthermie. An\u00e4sth Intensivmed 59:204\u2013208","journal-title":"An\u00e4sth Intensivmed"},{"key":"462_CR2","first-page":"483","volume":"49","author":"Deutsche Gesellschaft f\u00fcr An\u00e4sthesiologie und Intensivmedizin","year":"2008","unstructured":"Deutsche Gesellschaft f\u00fcr An\u00e4sthesiologie und Intensivmedizin (2008) Empfehlung zur Therapie der malignen Hyperthermie. An\u00e4sth Intensivmed 49:483\u2013488","journal-title":"An\u00e4sth Intensivmed"},{"key":"462_CR3","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/bja\/aeq243","volume":"105","author":"KPE Glahn","year":"2010","unstructured":"Glahn KPE, Ellis FR, Halsall PJ et\u00a0al (2010) Managing a\u00a0malignant hyperthermia crisis\u2014guidelines from the European Malignant Hyperthermia Group. Br J Anaesth 105:417\u2013420","journal-title":"Br. J. Anaesth."},{"key":"462_CR4","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00101-014-2351-6","volume":"63","author":"S Wolak","year":"2014","unstructured":"Wolak S, R\u00fccker B, Kohlschmidt N et al (2014) Homozygote und \u201ecompound\u201c-heterozygote RYR1-Mutationen. Anaesthesist 63:643\u2013650","journal-title":"Anaesthesist"},{"key":"462_CR5","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1055\/s-2007-994238","volume":"33","author":"E Hartung","year":"1998","unstructured":"Hartung E, Anetseder M, Olthoff D et\u00a0al (1998) Die regionale Verbreitung der Maligne Hyperthermie Veranlagung in Deutschland: Stand 1997. Anasthesiol Intensivmed Notfallmed Schmerzther 33:238\u2013243","journal-title":"Anasthesiol. Intensivmed. Notfallmed. Schmerzther."},{"key":"462_CR6","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1097\/00000542-200606000-00008","volume":"104","author":"CA Ibarra","year":"2006","unstructured":"Ibarra CA, Wu S, Murayama K et\u00a0al (2006) Malignant hyperthermia in Japan\u2014mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing. Anesthesiology 104:1146\u20131154","journal-title":"Anesthesiology"},{"key":"462_CR7","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1097\/00000542-200211000-00007","volume":"97","author":"N Monnier","year":"2002","unstructured":"Monnier N, Krivosic-Horber R, Payen JF et al (2002) Presence of two different genetic traits in malignant hyperthermia families: implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility. Anesthesiology 97:1067\u20131074","journal-title":"Anesthesiology"},{"key":"462_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/ALN.0b013e318190bb08","volume":"110","author":"E Rosero","year":"2009","unstructured":"Rosero E, Adesanva A, Timaran C, Joshi G (2009) Trends and outcomes of malignant hyperthermia in the United States 2000\u20132005. Anesthesiology 110:89\u201394","journal-title":"Anesthesiology"},{"key":"462_CR9","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1213\/01.ANE.0000184184.40504.F3","volume":"101","author":"T Podranski","year":"2005","unstructured":"Podranski T, Bouillon T, Schumacher PM et\u00a0al (2005) Compartmental pharmacokinetics of dantrolene in adults: do malignant hyperthermia association dosing guidelines work? Anesth Analg 101:1695\u20131699","journal-title":"Anesth Analg"},{"key":"462_CR10","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1365-2044.2004.03658.x","volume":"59","author":"Th Krause","year":"2004","unstructured":"Krause Th, Gerbershagen MU, Fiege M et\u00a0al (2004) Dantrolene\u2014a\u00a0review of its pharmacology, therapeutic use and new developments. Anaesthesia 59:364\u2013373","journal-title":"Anaesthesia"},{"key":"462_CR11","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/EJA.0b013e3283439545","volume":"28","author":"JK Sch\u00fctte","year":"2011","unstructured":"Sch\u00fctte JK, Becker S, Burmester S et\u00a0al (2011) Comparison of the therapeutic effectiveness of a\u00a0dantrolene sodium solution and a\u00a0novel nanocrystalline suspension of dantrolene sodium in malignant hyperthermia normal and susceptible pigs. Eur J Anaesthesiol 28:256\u2013264","journal-title":"Eur J Anaesthesiol"},{"key":"462_CR12","first-page":"526","volume":"58","author":"F Wappler","year":"2017","unstructured":"Wappler F, Geldner G, Zwi\u00dfler B (2017) Auf dem Trockenen \u2013 oder wie l\u00f6st man in Zukunft Dantrolen auf? An\u00e4sth Intensivmed 58:526\u2013528","journal-title":"An\u00e4sth Intensivmed"},{"key":"462_CR13","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1097\/EJA.0b013e32833b1adf","volume":"27","author":"J Mellin-Olsen","year":"2010","unstructured":"Mellin-Olsen J, Staender S, Whitaker DK, Smith AF (2010) The Helsinki declaration on patient safety in anaesthesiology. Eur J Anaesthesiol 27:592\u2013597","journal-title":"Eur. J. Anaesthesiol."},{"key":"462_CR14","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1056\/NEJMsa1204720","volume":"368","author":"AF Arriaga","year":"2013","unstructured":"Arriaga AF, Bader AM, Wong JM et al (2013) Simulation-based trial of surgical-crisis checklists. N\u00a0Engl J Med 368:246\u2013253","journal-title":"N Engl J Med"},{"key":"462_CR15","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1097\/ACO.0b013e328332a45b","volume":"22","author":"BW Brandom","year":"2009","unstructured":"Brandom BW (2009) Ambulatory surgery and malignant hyperthermia. Curr Opin Anaesthesiol 22:744\u2013747","journal-title":"Curr Opin Anaesthesiol"},{"key":"462_CR16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/0310057X0603400114","volume":"34","author":"N Pollock","year":"2006","unstructured":"Pollock N, Langton E, McDonnell N et\u00a0al (2006) Malignant hyperthermia and day surgery. Anaesth Intensive Care 34:40\u201345","journal-title":"Anaesth. Intensive Care."}],"container-title":["Der Anaesthesist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00101-018-0462-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-018-0462-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-018-0462-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T08:35:08Z","timestamp":1604478908000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00101-018-0462-1"}},"subtitle":["Update 2018"],"short-title":[],"issued":{"date-parts":[[2018,6,26]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["462"],"URL":"https:\/\/doi.org\/10.1007\/s00101-018-0462-1","relation":{},"ISSN":["0003-2417","1432-055X"],"issn-type":[{"value":"0003-2417","type":"print"},{"value":"1432-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,26]]},"assertion":[{"value":"26 June 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F.\u00a0Wappler gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine vom Autor durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}